Heart Failure

View the latest content related to this topic

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

The agency’s decision, based on FINEARTS-HF, extends the option for MRA-based therapy beyond patients with reduced LVEF.

Caitlin E. Cox

July 14, 2025

Slides

See all

Presentation ACC 2025

FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality

Presenter: Stefan D. Anker

March 30, 2025

Presentation ACC 2025

The MIGHTy-Heart Randomized Clinical Trial

Presenter: Ruth Masterson Creber

March 30, 2025

Presentation ACC 2025

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Presenter: Roland R. Van Kimmenade

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

Presentation THT 2025

Voice of the Heart: SQ ICM for Heart Failure Using ECG and Heart Sounds as Biomarkers

Presenter: Jaeson Bang

February 13, 2025

News

See all

News Daily News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

By Caitlin E. Cox

July 14, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

By Yael L. Maxwell

July 03, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2025

By Michael O'Riordan

June 30, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

By L.A. McKeown

June 26, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

By Michael O'Riordan

June 25, 2025

ACC 2025

March 29

March 31, 2025

CTO 2025

February 28

March 01, 2025

THT 2025

February 11

February 13, 2025

Videos on This Topic

See all

Advertisement

Heart Failure

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

Slides

FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality

The MIGHTy-Heart Randomized Clinical Trial

Liberal Fluid Intake versus Fluid Restriction in Chronic Heart Failure: The FRESH-UP Study

Dapagliflozin after Transcatheter Aortic Valve Implantation

Voice of the Heart: SQ ICM for Heart Failure Using ECG and Heart Sounds as Biomarkers

News

FDA Approves Finerenone for HF Patients With Mildly Reduced or Preserved EF

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

TCTMD’s Top 10 Most Popular Stories for June 2025

June 2025 Dispatch for the CV Team

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

More on This Topic

Conference Coverage

ACC 2025

CTO 2025

THT 2025

Videos on This Topic

Advertisement

Heart Failure

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content